TherapeuticsMD Inc (TXMD)
1.95
-0.04
(-2.01%)
USD |
NASDAQ |
Apr 15, 16:00
1.96
+0.01
(+0.51%)
After-Hours: 20:00
TherapeuticsMD Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.00% |
| June 30, 2022 | 0.00% |
| March 31, 2022 | 0.00% |
| December 31, 2021 | 80.67% |
| September 30, 2021 | 79.21% |
| June 30, 2021 | 82.04% |
| March 31, 2021 | 76.41% |
| December 31, 2020 | 75.28% |
| September 30, 2020 | 83.05% |
| June 30, 2020 | 58.88% |
| March 31, 2020 | 77.84% |
| December 31, 2019 | 81.90% |
| September 30, 2019 | 93.91% |
| June 30, 2019 | 79.46% |
| March 31, 2019 | 80.67% |
| December 31, 2018 | 81.32% |
| September 30, 2018 | 79.87% |
| June 30, 2018 | 87.93% |
| March 31, 2018 | 83.21% |
| December 31, 2017 | 85.58% |
| September 30, 2017 | 84.14% |
| June 30, 2017 | 83.96% |
| March 31, 2017 | 83.45% |
| December 31, 2016 | 84.18% |
| September 30, 2016 | 77.65% |
| Date | Value |
|---|---|
| June 30, 2016 | 74.33% |
| March 31, 2016 | 77.52% |
| December 31, 2015 | 78.05% |
| September 30, 2015 | 77.00% |
| June 30, 2015 | 78.69% |
| March 31, 2015 | 76.68% |
| December 31, 2014 | 79.34% |
| September 30, 2014 | 74.47% |
| June 30, 2014 | 76.20% |
| March 31, 2014 | 70.65% |
| December 31, 2013 | 83.68% |
| September 30, 2013 | 71.74% |
| June 30, 2013 | 77.72% |
| March 31, 2013 | 75.26% |
| December 31, 2012 | 73.18% |
| September 30, 2012 | 70.40% |
| June 30, 2012 | 54.54% |
| March 31, 2012 | 53.43% |
| December 31, 2011 | 52.62% |
| September 30, 2011 | 55.21% |
| June 30, 2011 | 52.99% |
| March 31, 2011 | 58.06% |
| December 31, 2010 | 55.20% |
| September 30, 2010 | |
| June 30, 2010 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2022
93.91%
Maximum
Sep 2019
62.05%
Average
78.52%
Median
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Ampio Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -33.01% |
| Return on Assets | -17.27% |
| Return on Invested Capital | -33.01% |
| Profit Margin (Quarterly) | -175.9% |
| Operating Margin (Quarterly) | -320.9% |
| Return on Net Operating Assets | -42.52% |